Cultural advice

The Australian National University acknowledges, celebrates and pays our respects to the Ngunnawal and Ngambri people of the Canberra region and to all First Nations Australians on whose traditional lands we meet and work, and whose cultures are among the oldest continuing cultures in human history.

Aboriginal and Torres Strait Islander peoples are advised that ANU Library collections may include images, names, voices, and other representations of deceased persons.

Material in the collection may contain terms, language or views that reflect the period in which the item was created and may be considered inappropriate today.

Modulation of the proteolytic activity of the complement protease C1s by polyanions: implications for polyanion-mediated acceleration of interaction between C1s and SERPING1

dc.contributor.authorMurray-Rust, Thomas A
dc.contributor.authorKerr, Felicity K
dc.contributor.authorThomas, Adele R
dc.contributor.authorWu, Tina
dc.contributor.authorYongqing, Tang
dc.contributor.authorOng, Poh C
dc.contributor.authorQuinsey, Noelene S
dc.contributor.authorWhisstock, James C
dc.contributor.authorWagenaar-Bos, Ineke C.
dc.contributor.authorFreeman, Craig
dc.contributor.authorPike, Robert N
dc.date.accessioned2015-12-08T22:26:30Z
dc.date.issued2009
dc.date.updated2016-02-24T11:37:32Z
dc.description.abstractThe complement system plays crucial roles in the immune system, but incorrect regulation causes inflammation and targeting of self-tissue, leading to diseases such as systemic lupus erythematosus, rheumatoid arthritis and age-related macular degeneration. In vivo, the initiating complexes of the classical complement and lectin pathways are controlled by SERPING1 [(C1 inhibitor) serpin peptidase inhibitor, clade G, member 1], which inactivates the components C1s and MASP-2 (mannan-binding lectin serine peptidase 2). GAGs (glycosaminoglycan) and DXS (dextran sulfate) are able to significantly accelerate SERPING1-mediated inactivation of C1s, the key effector enzyme of the classical C1 complex, although the mechanism is poorly understood. In the present study we have shown that C1s can bind to DXS and heparin and that these polyanions enhanced C1s proteolytic activity at low concentrations and inhibited it at higher concentrations. The recent determination of the crystal structure of SERPING1 has given rise to the hypothesis that both the serpin (serine protease inhibitor)-polyanion and protease-polyanion interactions might be required to accelerate the association rate of SERPING1 and C1s. To determine what proportion of the acceleration was due to protease-polyanion interactions, a chimaeric mutant of α1-antitrypsin containing the P4-P1 residues from the SERPING1 RCL (reactive-centre loop) was produced. Like SERPING1, this molecule is able to effectively inhibit C1s, but is unable to bind polyanions. DXS exerted a biphasic effect on the association rate of C1s which correlated strongly with the effect of DXS on C1s proteolytic activity. Thus, whereas polyanions are able to bind C1s and modulate its activity, polyanion interactions with SERPING1 must also play a vital role in the mechanism by which these cofactors accelerate the C1s-SERPING1 reaction.
dc.identifier.issn0264-6021
dc.identifier.urihttp://hdl.handle.net/1885/33666
dc.publisherPortland Press
dc.sourceBiochemical Journal
dc.subjectKeywords: C1 inhibitor; Complement; Glycosaminoglycan (GAG); Protease; SERPING1; Amino acids; Crystal structure; Glucose; Pathology; Polysaccharides; Association reactions; alpha 1 antitrypsin; complement component C1; dextran sulfate; mutant protein; polyanion; pr C1 inhibitor; Complement; Glycosaminoglycan (GAG); Protease; SERPING1
dc.titleModulation of the proteolytic activity of the complement protease C1s by polyanions: implications for polyanion-mediated acceleration of interaction between C1s and SERPING1
dc.typeJournal article
local.bibliographicCitation.lastpage303
local.bibliographicCitation.startpage295
local.contributor.affiliationMurray-Rust, Thomas A, Monash University
local.contributor.affiliationKerr, Felicity K, Monash University
local.contributor.affiliationThomas, Adele R, Monash University
local.contributor.affiliationWu, Tina, Monash University
local.contributor.affiliationYongqing, Tang, Monash University
local.contributor.affiliationOng, Poh C, Monash University
local.contributor.affiliationQuinsey, Noelene S, Monash University
local.contributor.affiliationWhisstock, James C, Monash University
local.contributor.affiliationWagenaar-Bos, Ineke C., University of Amsterdam
local.contributor.affiliationFreeman, Craig, College of Medicine, Biology and Environment, ANU
local.contributor.affiliationPike, Robert N, Monash University
local.contributor.authoruidFreeman, Craig, u9113554
local.description.embargo2037-12-31
local.description.notesImported from ARIES
local.identifier.absfor111506 - Toxicology (incl. Clinical Toxicology)
local.identifier.ariespublicationu6800332xPUB104
local.identifier.citationvolume422
local.identifier.doi10.1042/BJ20090198
local.identifier.scopusID2-s2.0-70149096856
local.identifier.thomsonID000269429900011
local.type.statusPublished Version

Downloads

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
01_Murray-Rust_Modulation_of_the_proteolytic_2009.pdf
Size:
537.24 KB
Format:
Adobe Portable Document Format
abcd